Endocrine and Metabolism

Principles of Hormonal Regulation and Therapeutic AdjustmentPharmacoclinical Fundamentals

MetforminBiguanids

Empagliflozin (and Dapagliflozin)SGLT2 inhibitors

Liraglutide / SemaglutideIncretin Analogues / GLP-1 Receptor Agonists

SitagliptinDPP-4 inhibitors / Gliptins

GlimepirideSulfonylureas

PioglitazoneThiazolidinediones / Insulin Sensitizers

Insulin Glargine and Insulin LisproAnalog Insulins / Biological Therapy

Levothyroxine Sodium (T4)Thyroid Hormones

Methimazole (Thiamazole) and Propyl hysteractyl (PTU)Synthetic Antithyroids / Thionamides

Dexamethasone and HydrocortisoneSystemic Glucocorticoids

Fludrocortisone AcetateSynthetic Mineralocorticoids

Cabergoline and OctreotidePituitary Modulators

Desmopressin (DDAVP)Vasopressin Analogues / Antidiuretic Hormones

Alendronate Sodium and Zoledronic AcidBone Metabolism Modulators / Bisphosphonates

Denosumab and TeriparatideBiological Therapy and Bone Anabolics

Cinacalcet HydrochlorideCalcium Receptor Modulators / Calcimimetics

Atorvastatin (and Evolocumab)Hypolipidemics and Cholesterol Regulators

Integrated Fit and Safety SummaryComparative Table of Clinical Settings